Jecko Thachil/LinkedIn
Mar 9, 2026, 14:10
Jecko Thachil: The Journey of Protamine – From Heparin Reversal to Potential Gene Therapy Applications
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about his recent article, adding:
“Protamine is a very useful drug in reversing heparin and has been used for several years.
How did its journey start from the discovery of DNA and now may be relevant for gene therapy?”
Title: Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy
Author: Jecko Thachil
Read the Full Article on Seminars in Thrombosis and Hemostasis
Other posts featuring Jecko Thachil on Hemostasis Today.
-
Apr 26, 2026, 12:51Michael Stark: Join the Discussion on Cord Blood vs Adult Blood
-
Apr 26, 2026, 12:21Alex John London: AI in Healthcare Must Show Safety and Efficacy Before Use
-
Apr 26, 2026, 12:01David McIntosh: Raising Awareness on the Worldwide Shortage of Plasma-Derived Medicines
-
Apr 26, 2026, 12:00José Antonio García Erce: Where Is the Limit in Blood Donation Age?
-
Apr 26, 2026, 11:59Tomas Holubec: A New Chapter in Cardiac Surgery in Nuremberg
-
Apr 26, 2026, 11:58Emna Hammami: Great First Session at the EHA SWG Scientific Meeting on Bleeding and Platelet Disorders
-
Apr 26, 2026, 11:56Sami Moellmer-Gomez: Glad to Present My Recent Work at the UNC 12th Symposium on Hemostasis
-
Apr 26, 2026, 11:55Brian O Mahony: Pierce Highlights Unique Inhibitor Cases in AAV-ET3 FVIII Gene Therapy Trial
-
Apr 26, 2026, 11:51Mavis Agnes Kisakye: A Patient Story That Shows the Power of Humanitarian Aid